The Global Smoking Cessation and Nicotine De-addiction Market is expected to grow by USD 16.6 bn during 2020-2024, progressing at a CAGR of 13% during the forecast period
NEW YORK, March 16, 2020 /PRNewswire/ --
Global Smoking Cessation And Nicotine De-addiction Market 2020-2024 The analyst has been monitoring the global smoking cessation and nicotine de-addiction market 2020-2024 and it is poised to grow by USD 16.6 bn during 2020-2024, progressing at a CAGR of 13% during the forecast period. Our reports on global smoking cessation and nicotine de-addiction market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing number of people trying to quit smoking. In addition, product innovations is anticipated to boost the growth of the global smoking cessation and nicotine de-addiction market 2020-2024 as well. Market Segmentation The global smoking cessation and nicotine de-addiction market 2020-2024 is segmented as below: Product: -- E-cigarette -- NRT -- Drug Therapy Geographic Segmentation: -- APAC -- Europe -- MEA -- North America -- South America Key Trends for global smoking cessation and nicotine de-addiction market 2020-2024 growth This study identifies product innovations as the prime reasons driving the global smoking cessation and nicotine de-addiction market 2020-2024 growth during the next few years. Prominent vendors in global smoking cessation and nicotine de-addiction market 2020-2024 We provide a detailed analysis of around 25 vendors operating in the global smoking cessation and nicotine de-addiction market 2020-2024, including some of the vendors such as British American Tobacco Plc, Cipla Ltd., Dr. Reddy's Laboratories Ltd., GlaxoSmithKline Plc, Imperial Brands Plc, Japan Tobacco Inc., Johnson & Johnson Services Inc., JUUL Labs Inc., Pfizer Inc. and Philip Morris International Inc. . The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Read the full report: https://www.reportlinker.com/p05866822/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
